Beijing Chunlizhengda Medical Instruments (1858) Announces H Shareholders’ Class Meeting Arrangements

Bulletin Express10-31

Beijing Chunlizhengda Medical Instruments Co., Ltd. (Stock Code: 1858) has released a notice regarding its H Shareholders’ Class Meeting, scheduled for 19 November 2025 at No. 10 Xinmi Xi Er Road, Southern District of Tongzhou Economic Development Zone, Tongzhou District, Beijing, PRC. The meeting is set to commence at 2:00 p.m. or immediately following the conclusion of the Class Meeting of A Shareholders held on the same day.

According to the notice, H shareholders are entitled to attend and vote on key proposals, including the abolishment of the Supervisory Committee and corresponding amendments to the Articles of Association, as well as proposed revisions to the Rules of Procedures of the General Meetings and the Rules of Procedures of the Board Meetings. Shareholders may appoint proxies and submit the relevant proxy form and authorization documents to the designated H share registrar no later than 24 hours before the meeting. Further details about the resolutions and voting instructions can be found in the circular dated 30 October 2025.

This announcement emphasizes the importance of punctual form submissions and accurate identification for shareholders intending to vote. Any jointly held H shares may be voted by one holder on behalf of all joint holders, in accordance with the register of members. The notice specifies that shareholders who personally attend and vote at the meeting will supersede any previously submitted proxy documents.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment